Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature
Alicia Smart(Brigham and Women's Hospital), Jonathan D. Schoenfeld(Brigham and Women's Hospital)
Cited by 16
Related Papers
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
|JAMA Oncology|2020|340
Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
|British Journal of Cancer|2016|84